As part of MossRehab’s ongoing commitment to quality and transparency, we choose to undergo triennial reviews by the Commission for Accreditation of Rehabilitation Facilities (CARF). This year, we are proud to announce that CARF’s comprehensive survey and inspection of all of our operations has resulted in three-year accreditation for a total of 15 MossRehab programs. [...]
|
MossRehab will soon begin the exclusive U.S. clinical trial for a new assistive technology called the ReWalk. The ReWalk is a motorized exoskeleton suit that enables patients with lower limb disabilities, including complete paralysis, to independently engage in ambulatory activities, such as standing, walking and in some cases climbing stairs.The ReWalk consists of a lightweight [...]
|
by Laurel J. Buxbaum, PsyD, Mary Ann Palermo, Dina Mastrogiovanni, Mary Schmidt Read, Ellen Rosenberg-Pitonyak, Albert A. Rizzo, H. Branch Coslett Moss Rehabilitation Research Institute, Philadelphia, PA, USA A total of 9 participants with right-hemisphere stroke performed a new virtual reality (VR) wheelchair navigation test of lateralized spatial attention and neglect. The test consists of [...]
|
by Michael Saulino, MD Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, PA. STUDY DESIGN: Case report. OBJECTIVES: To report a novel management strategy for neuropathic pain management after spinal cord injury. SETTING: Outpatient spinal cord injury (SCI) clinic. METHODS: The patient demonstrated two neuropathic pain syndromes, namely at- and below-level pain. These syndromes [...]
|
by H. Barbeau, PhD, R. Elashoff, PhD, D. Deforge, MD, J. Ditunno, MD, M. Saulino, MD, B.H. Dobkin, MD McGill University/Institut de Readaptation de Montreal, Montreal, Quebec, Canada. BACKGROUND: Timed walking speed for 6 to 15 m and the distance walked in 2 to 12 minutes are frequently used outcome measures in rehabilitation trials, presumably [...]
|
by Leonard Kamen, DO, Herbert R. Henney, Jacob D. Runyan Albert Einstein Medical Center, Moss Rehabilitation Outpatient Center, Philadelphia, PA, USA. OBJECTIVE: Tizanidine is an imidazoline central alpha(2)-adrenoceptor agonist widely used to manage spasticity secondary to conditions such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI). While there is widespread use of tizanidine [...]
|
by Junghoon Kim, Brian Avants, Sunil Patel, John Whyte, MD, PhD, Branch H. Coslett, MD, John Pluta, John A. Detre, James C. Gee Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, PA Traumatic brain injury (TBI) is one of the most common causes of long-term disability. Despite the importance of identifying neuropathology in individuals [...]
|
by Carlos D. Marquez de la Plata, PhD, Tessa Hart, PhD, Flora M. Hammond, MD, Alan B. Frol, PhD, Anne Hudak, MD, Caryn R. Harper, MS, Therese M. O’Neil-Pirozzi, ScD, John Whyte, MD, PhD, Mary Carlile, MD, Ramon Diaz-Arrastia, MD, PhD Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. OBJECTIVE: To determine whether older persons are at increased risk for progressive [...]
|
by John Whyte, MD, PhD, Monica Vaccaro, MA, Patricia Grieb-Neff, MS, Tessa Hart, PhD, Marcia Polansky, ScD, H. Branch Coslett, MD Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, Pennsylvania. OBJECTIVE: To evaluate the effects of bromocriptine on a variety of aspects of attention, ranging from laboratory-based impairment measures to caregiver ratings and work productivity, [...]
|
by Laurel J. Buxbaum, PsyD, Kathleen Y. Haaland, Phd, Mark Hallett, MD, Lewis Wheaton, PhD, Kenneth M. Heilman, MD, Amy Rodriguez, MA, CCC-SLP, Leslie J. Gonzalez-Rothi, PhD Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, PA. Limb apraxia is a common disorder of skilled, purposive movement that is frequently associated with stroke and degenerative diseases [...]
|
by Alberto Esquenazi, MD, Nathaniel Mayer, MD, Roser Garreta, MD Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, Pennsylvania, USA. OBJECTIVE: To assess whether walking velocity could be improved in patients with disorders related to upper-motor neuron syndrome (UMNS) by treating elbow flexor spasticity with botulinum toxin type A (BoNTA). DESIGN: This was a [...]
|
by Mary G. Klein, PhD, Leonard E. Braitman, PhD, Roberta Costello, MS, RN, Mary Ann Keenan, MD, Albert Esquenazi, MD Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, PA; Thomas Jefferson University, Philadelphia PA. OBJECTIVE: To examine factors associated with daily step activity, perceived activity, maximum walking speed, and walking speed reserve over time [...]
|
